Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Can a New Drug Candidate Cure Pancreatic Cancer?
New $15 Million Grant to Dana-Farber Scientists Supports Research into Innovative Approaches to Endometrial Cancer Treatment
Unraveling the Menin Mystery to Halt Cancer Growth
Cedars-Sinai Cancer’s Blood and Marrow Transplant Patients Experience Superior Outcomes
Dana-Farber Researchers Explore AI's Potential Roles in Predicting and Diagnosing Cancer
Ancient DNA Reveals Origin of Racial/Ethnic Disparity in a Childhood Cancer
Breast Cancer Trial Aims to Improve Treatment for Men
Dana-Farber Cancer Institute Launches Neuro-Inclusive Oncology Care and Empowerment Program
Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
Bispecific Antibody Therapies for Lymphoma
Pediatric Cancer Expert Explains New Options for Children With Sarcomas
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Dana-Farber and Gustave Roussy to Hold Third Transatlantic Exchange: Annual Scientific Conference Dedicated to Advancing Oncology Research and Practice
BCL2 Inhibitors: What’s the Latest Research?
Showing 61 - 75 of 1027 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
